美国FDA宣布了自愿减少的第二阶段目标,目标是平均每日摄入量减少20%. US FDA announces Phase II of voluntary sodium reduction targets, aiming for a 20% decrease in average daily sodium intake.
美国食品和药物管理局宣布了其自愿减少的目标的第二阶段,旨在将每天平均摄入量降至每人2,750毫克,比2021年之前的消费者摄入量减少20%. The US FDA has announced Phase II of its voluntary sodium reduction targets, aiming to lower average daily sodium intake to 2,750 mg per person, a 20% reduction from consumer intake levels prior to 2021. 该倡议的重点是商业加工、包装和制成食品,并遵循2021年10月发布的一套初步目标。 The initiative focuses on commercially processed, packaged, and prepared foods, and follows the initial set of targets issued in October 2021. 减少食物供应中的钠有可能通过帮助降低心脏病和中风的风险,防止数十万的过早死亡和疾病。 Reducing sodium in the food supply has the potential to prevent hundreds of thousands of premature deaths and illnesses by helping to reduce the risk of heart disease and stroke.